AR and PI3K Genomic Profiling of Cell-free DNA Can Identify Poor Responders to Lutetium-177-PSMA Among Patients with Metastatic Castration-resistant Prostate Cancer
Jan Pieter Vanwelkenhuyzen, Eva Van Bos, Siska Van Bruwaene, Karl Lesage, Alex Maes, Sezgin Üstmert, Filip Lavent, Laurence Beels, Henrik Grönberg, Piet Ost, Johan Lindberg, Bram De Laere
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.1016/j.euros.2023.05.008 ↗
- Volume · Issue · Pages
- 53 · — · 63-66
- Publisher
- Elsevier BV
- Article URL
- https://doi.org/10.1016/j.euros.2023.05.008 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
30 May 2023
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 30 May 2023 | OpenAlex |
Keywords (as given): lutetium-177 PSMA; metastatic castration-resistant prostate cancer; cell-free DNA; circulating tumor DNA; PI3K signaling; prognostic factors; progression-free survival; radioligand therapy; TP53; TMPRSS2-ERG fusion; treatment response
HEC Status at Publication Not the journal's current status
HEC Status at PublicationConclusive
HEC status at publication
Recognized
X
Based on the recorded HEC dataset applicable to the article's publication date. Listed as X in the HEC list for 2022–23.
- Journal
- European Urology Open Science
- Publication date used
- 30 May 2023 (OpenAlex publication date)
- Applicable HEC period
- 2022–23 (version 2) · 01 Jul 2022 – 30 Jun 2023
- Category
- X
- Recognition status
- Recognized (OK_RECORD_FOUND)
- Source
- hjrs-2022-23 row 22953
- Verification status
- Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.